ZA963269B - Modified polypeptides for enhanced immunogenicity - Google Patents

Modified polypeptides for enhanced immunogenicity

Info

Publication number
ZA963269B
ZA963269B ZA963269A ZA963269A ZA963269B ZA 963269 B ZA963269 B ZA 963269B ZA 963269 A ZA963269 A ZA 963269A ZA 963269 A ZA963269 A ZA 963269A ZA 963269 B ZA963269 B ZA 963269B
Authority
ZA
South Africa
Prior art keywords
modified polypeptides
enhanced immunogenicity
immunogenicity
enhanced
polypeptides
Prior art date
Application number
ZA963269A
Other languages
English (en)
Inventor
Nicolas Joseph Fasel
Christopher Dominique Reymond
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of ZA963269B publication Critical patent/ZA963269B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA963269A 1995-04-25 1996-04-24 Modified polypeptides for enhanced immunogenicity ZA963269B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201066 1995-04-25
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity

Publications (1)

Publication Number Publication Date
ZA963269B true ZA963269B (en) 1996-10-25

Family

ID=26139248

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963269A ZA963269B (en) 1995-04-25 1996-04-24 Modified polypeptides for enhanced immunogenicity

Country Status (15)

Country Link
US (1) US6113917A (cs)
EP (1) EP0826050A1 (cs)
JP (1) JPH11504215A (cs)
AU (1) AU714808B2 (cs)
BR (1) BR9604989A (cs)
CA (1) CA2218987A1 (cs)
CZ (1) CZ291013B6 (cs)
HU (1) HUP9802238A3 (cs)
IL (1) IL118021A0 (cs)
NL (1) NL1001348C2 (cs)
NO (1) NO974924L (cs)
NZ (1) NZ307195A (cs)
PL (1) PL323078A1 (cs)
WO (1) WO1996034105A1 (cs)
ZA (1) ZA963269B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504223A (ja) * 1996-01-29 2000-04-11 ジョージタウン・ユニヴァーシティ Ｍｓａ１ペブチドの付加に基づいたマラリアワクチン
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
KR20100039911A (ko) * 2001-10-13 2010-04-16 아스테리온 리미티드 폴리펩타이드들을 포함하는 글리코실포스파티딜이노시톨
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
US8038986B2 (en) 2002-07-26 2011-10-18 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and diagnostic and therapeutic uses thereof
US7625998B2 (en) 2003-04-09 2009-12-01 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol
US20080026008A1 (en) * 2006-07-27 2008-01-31 Clark Tibbs Bacteriophage DNA vaccine vector
KR20240021211A (ko) * 2021-06-10 2024-02-16 얀센 바이오테크 인코포레이티드 Klk2-gpi 융합 단백질에 대한 핵산 코딩, 재조합 세포 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen
NL9100869A (nl) * 1991-05-17 1992-12-16 Univ Lausanne Dictyostelide expressievector en werkwijze voor het tot expressie brengen van een gewenst eiwit.
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos

Also Published As

Publication number Publication date
US6113917A (en) 2000-09-05
CZ291013B6 (cs) 2002-11-13
HUP9802238A3 (en) 2000-03-28
HUP9802238A2 (hu) 1999-01-28
AU714808B2 (en) 2000-01-13
IL118021A0 (en) 1996-08-04
CZ337897A3 (cs) 1998-04-15
AU5648196A (en) 1996-11-18
WO1996034105A1 (en) 1996-10-31
PL323078A1 (en) 1998-03-02
NO974924D0 (no) 1997-10-24
NZ307195A (en) 1999-07-29
NL1001348C2 (en) 1996-10-28
BR9604989A (pt) 1999-11-30
NO974924L (no) 1997-12-19
JPH11504215A (ja) 1999-04-20
EP0826050A1 (en) 1998-03-04
CA2218987A1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
EP0793502A4 (en) NEW POLYPEPTIDES DERIVED FROM HEDGEHOG
GB9513261D0 (en) Vaccines
PT1090128E (pt) Polipéptidos dependentes da vitamina k modificados
HUP9800299A3 (en) Gnrh-leukotoxin chimeras
IL129295A0 (en) Novel hedgehog-derived polypeptides
GB9500601D0 (en) Modified peptides
PL318017A1 (en) Peptides
HUP9802238A3 (en) Modified polypeptides for enhanced immunogenicity
GB9425380D0 (en) Peptides
GB9413751D0 (en) Immunodominant peptides
GB9519511D0 (en) Peptides
GB2308509B (en) Services-connections for trailer-vehicles
GB9425381D0 (en) Peptides
GB2308393B (en) Windshelter for sun-bathing
GB2298174B (en) Services-connections for trailer-vehicles
GB9517269D0 (en) Vaccines
GB9514580D0 (en) Polypeptide
GB9514835D0 (en) Polypeptide
GB9511092D0 (en) Peptides
ZA956331B (en) Peptides
GB9421408D0 (en) Peptides
GB9518946D0 (en) Vaccines
GB9514088D0 (en) Vaccines
GB9505059D0 (en) Vaccines
ZA962612B (en) Vaccines